How Does Supplemental Medicare Coverage Affect the Disabled Under-65 Population?: An Exploratory Analysis of the Health Effects of States' Medigap Policies for SSDI Beneficiaries / Philip Armour, Claire O'Hanlon.

Format:

Book

Author/Creator:

Armour, Philip.

Contributor:

National Bureau of Economic Research.

O'Hanlon, Claire.

Series:

Working Paper Series (National Bureau of Economic Research) no. w25564.

NBER working paper series no. w25564

Language:

English

Physical Description:

1 online resource: illustrations (black and white);

Other Title:

How Does Supplemental Medicare Coverage Affect the Disabled Under-65 Population?

Place of Publication:

Cambridge, Mass. National Bureau of Economic Research 2019.

Summary:

A substantial portion of the costs associated with, and the value to beneficiaries of, Social Security Disability Insurance is Medicare eligibility. However, the benefits of this eligibility can vary due to differences in state policies on supplemental Medicare coverage, also known as Medigap. Although Medigap policies are federally regulated to be issued to 65-and-over Medicare beneficiaries with specific restrictions over underwriting, these policies are left to states to regulate with regard to the under-65 SSDI population, generating substantial cross-state and temporal variation. This paper documents the variation in availability and generosity of under-65 Medigap eligibility for the SSDI population. Furthermore, it exploits this variation to provide initial estimates of how this eligibility affects the health status of non-Medicaid-eligible SSDI recipients. Our main finding is that requiring Medigap plans be offered for under-65 SSDI recipients substantially improves self-reported health of this population, with suggestive evidence that this improvement is stronger as underwriting restrictions increase and among SSDI beneficiaries with mental health conditions. The estimated effect is highly robust to alternative scaling or categorizations of self-reported health, choice of data set, inclusion of fixed effects, controls for local Medicare Advantage penetration, and falsification tests. This effect is nearly three times the size of the estimated increase in self-reported health in the Oregon Medicaid expansion.

Notes:

Print version record

February 2019.